Biotechnology & Life Sciences

Stock Code

AOP

Stock Exchange

ax

Apollo Life Sciences (AOP) specialises in biotechnology. The Company develops, manufactures and markets therapeutics based on human proteins. The company aims to discover and commercialise human proteins as cure for disease and ageing. The innovative combined technologies of Apollo are deemed to produce more effectual and lower cost therapeutics, as compared to the first generation protein-based drugs. AOP listed on the ASX on 29 June, 2005.

Stock Code

AAH

Stock Exchange

ax

Arana Therapeutics (AAH) is a global biopharmaceutical Company actively involved in the research, development, production and distribution of peptide based medical products for use in the pharmaceutical and veterinary industries. The Company's head office is located in Sydney, Australia. Arana listed on the Australian Stock Exchange on 23 January, 1986. In August 2007, Peptech and EvoGenix merged to form Arana. The Company manufactures lead compounds intended for anti-inflammatory biologics market.

Stock Code

SIP

Stock Exchange

ax

Sigma Pharmaceuticals Limited (SIP) is a company engaged in manufacturing, marketing and distributing pharmaceutical products through drugstore and grocery channels. SIP also provides services to retail pharmacists. SIP was listed on the Australian Stock Exchange on the 30th of October 2002. Its average annual revenue reaches approximately $2.9 billion out of its issued capital of approximately $3.6 million. Its headquarters is located in Victoria, Australia and to date; around 2000 people are employed in the company.

Stock Code

PGL

Stock Exchange

ax

Progen Pharmaceuticals Limited (PGL) is a biotechnology company engaged in discovering, developing as well as commercialising the small molecule pharmaceutical for cancer treatment. PGL was listed on the Australian Stock Exchange on the 22nd of December 1995. Its average annual revenue reaches approximately $2.6 million out of its issued capital of $63 million. Its headquarters is located in Queensland, Australia and to date; around 40 people are employed in the company.

Stock Code

PBT

Stock Exchange

ax

Prana Biotechnology Limited (PBT) is a company engaged in researching about Alzheimer's disease as well as other type of age-related neurodegenerative diseases and disorders. It is also focused on developing pharmaceutical products that are exclusively designed and developed to treat and cure the root causes of the brain and eye degeneration as part of the aging processes. PBT was listed on the Australian Stock Exchange on the 28th of March 2000. Its average annual revenue reaches approximately $0.4 million out of its issued capital of approximately $53 million.

Stock Code

NRT

Stock Exchange

ax

Novogen Limited (NRT) is a pharmaceutical company engaged in the development, discovery, manufacturing, and marketing of different health products using the isoflavonoid technology. NRT was listed on the Australian Stock Exchange on the 1st of September 2003. Its average annual revenue reaches approximately $17 million out of its issued capital of approximately $137 million. Its headquarters is located in North Ryde, Australia and to date; around 75 people are employed in the company.

Stock Code

ABI

Stock Exchange

ax

Ambri (ABI) is a biotechnology development company. Its principal activities include integrating biotechnology, nanotechnology and electronics to make biosensors for medical and industrial applications. ABI listed on ASX on 16 June, 2000. AMBRI is engaged in the development of a biosensor platform incorporating AMBRI’s Ion Channel Switch (ICS) Technology to be used in the products for the human point-of-care diagnostic market. The ABI’s Ion Channel Switch (ICS) Technology is a patented, self-assembling synthetic bio-membrane, which is one of the first true 'bio nano' devices in the world.

Stock Code

ACL

Stock Exchange

ax

Alchemia (ACL) is a biotechnology company. The Company’s principal activities incorporate the development of carbohydrate-based molecules for therapeutic applications, based on its drug discovery and synthesis technologies. Alchemia was listed on the Australian Stock Exchange ASX on 23rd of December, 2003. Alchemia along with its subsidiaries is engaged in the research and development of new human pharmaceuticals.

Stock Code

LFE

Stock Exchange

ax

Life Therapeutics Ltd. (LFE) is a biotechnology company engaged in the research and development, manufacturing and marketing of haemostasis and separation technologies for the life science markets. LFE was listed on the Australian Stock Exchange (ASX) on the 8th of Mat 1986. Its average annual revenue reaches approximately $60 million out of its issued capital of $90 million. Its headquarters is located in New South Wales, Australia and to date; around 440 people are employed in the company. Life Therapeutics Ltd operates mainly in two business units: Life Sera and Life Diagnostics.

Stock Code

GTG

Stock Exchange

ax

Genetic Technologies (GTG) is a life science company engaged in the licensing of biotechnology patents as well as specialising in the fields of genomics and genetics with operations in Canada, Switzerland and Australia. GTG was listed on the Australian Stock Exchange on the 30th of July, 1987. Its average annual revenue reaches approximately $11 million out of its issued capital of $70 million. Its headquarters is located in Victoria Australia and to date; around 54 people are employed in the company.